Abstract:

Corneal neovascularization can lead to corneal hyalinity, visual acuity decline or even loss, which occurs in various corneal diseases. At present, many methods and measures (such as the use of glucocorticoids, immunosuppressive agents, non\|steroidal anti\|inflammatory drugs, anti\|vascular endothelial gowth factor drugs, tyrosine kinase inhibitors, some natural extracts, laser therapy, fine needle diathermy, gene therapy, combination therapy, etc.) have been used to prevent and treat corneal neovascularization, and have achieved varying degrees of success. However, these treatments for corneal neovascularization are only partially effective and may lead to some side effects. This article aims to review the latest treatment of corneal neovascularization.(Int Rev Ophthalmol, 2019, 43:   332\|336)